These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24613549

  • 1. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J, Schöpf V, Preusser M, Asenbaum U, Woitek R, Wöhrer A, Hainfellner JA, Wolfsberger S, Prayer D.
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [Abstract] [Full Text] [Related]

  • 2. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
    Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, Wick W, Bendszus M, Radbruch A.
    Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
    [Abstract] [Full Text] [Related]

  • 3. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging.
    Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer P, Weiler M, Roethke M, Sahm F, Schlemmer HP, Wick W, Heiland S, Bendszus M.
    Eur J Radiol; 2013 Mar; 82(3):552-6. PubMed ID: 23238364
    [Abstract] [Full Text] [Related]

  • 4. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC, Watkins TW, Kwan GN, Haacke EM.
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling.
    Furtner J, Oth I, Schöpf V, Nenning KH, Asenbaum U, Wöhrer A, Woitek R, Widhalm G, Kiesel B, Berghoff AS, Hainfellner JA, Preusser M, Prayer D.
    Clin Neuroradiol; 2020 Sep; 30(3):599-605. PubMed ID: 31263906
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A, Yamasaki F, Ohtaki M, Kajiwara Y, Takeshima Y, Watanabe Y, Takayasu T, Amatya VJ, Akiyama Y, Sugiyama K, Kurisu K.
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics.
    Maurer MH, Synowitz M, Badakshi H, Lohkamp LN, Wüstefeld J, Schäfer ML, Wiener E.
    Rofo; 2013 Mar; 185(3):235-40. PubMed ID: 23196836
    [Abstract] [Full Text] [Related]

  • 13. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X, Zhu Y, Kang H, Zhang Y, Liang H, Wang S, Zhang W.
    Cancer Imaging; 2015 Mar 21; 15(1):4. PubMed ID: 25889239
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z, You RX, Li J, Liu Y, Cao DR.
    Clin Neuroradiol; 2014 Dec 21; 24(4):329-36. PubMed ID: 23994941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?
    Aydın Ö, Büyükkaya R, Hakyemez B.
    Acta Radiol; 2017 Jan 21; 58(1):107-113. PubMed ID: 26966145
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.